These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 20023577

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
    Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C.
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):531-8. PubMed ID: 15965673
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
    Johnson ME, Murphy PJ, Boulton M.
    Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
    Toda I, Ide T, Fukumoto T, Ichihashi Y, Tsubota K.
    Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
    [Abstract] [Full Text] [Related]

  • 13. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA, Vehige JG.
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    Park Y, Song JS, Choi CY, Yoon KC, Lee HK, Kim HS.
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C.
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].
    Vandermeer G, Chamy Y, Pisella PJ.
    J Fr Ophtalmol; 2018 Mar; 41(3):238-245. PubMed ID: 29573863
    [Abstract] [Full Text] [Related]

  • 19. Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease.
    Baudouin C, Cochener B, Pisella PJ, Girard B, Pouliquen P, Cooper H, Creuzot-Garcher C.
    Eur J Ophthalmol; 2012 Mar; 22(5):751-61. PubMed ID: 22287172
    [Abstract] [Full Text] [Related]

  • 20. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye.
    Barabino S, Rolando M, Nardi M, Bonini S, Aragona P, Traverso CE.
    Eur J Ophthalmol; 2014 Mar; 24(2):173-8. PubMed ID: 24030535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.